{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:58:27Z","timestamp":1790827107123,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["MIUR-PRIN P2022HYWNR"],"award-info":[{"award-number":["MIUR-PRIN P2022HYWNR"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"DOI":"10.1007\/s11154-026-10090-1","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:33:03Z","timestamp":1790825583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond metabolic control: the potential role of antidiabetic therapies in modulating male reproductive function and spermatogenesis"],"prefix":"10.1007","author":[{"given":"Valentina","family":"Patern\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Abdel Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Delli Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Chiara","family":"Conflitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Maddaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanzo","family":"Gabriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Piticchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Le Moli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pallotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"1","key":"10090_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cen.13723","volume":"89","author":"M Grossmann","year":"2018","unstructured":"Grossmann M. Hypogonadism and male obesity: focus on unresolved questions. Clin Endocrinol. 2018;89(1):11\u201321. https:\/\/doi.org\/10.1111\/cen.13723.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10090_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrendo.2013.122","volume":"9","author":"PM Rao","year":"2013","unstructured":"Rao PM, Kelly DM, Jones TH. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol. 2013;9(8):479\u201393. https:\/\/doi.org\/10.1038\/nrendo.2013.122.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10090_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/nu11122975","volume":"11","author":"VA Giagulli","year":"2019","unstructured":"Giagulli VA, Castellana M, Murro I, et al. The role of diet and weight loss in improving secondary hypogonadism in men with obesity with or without type 2 diabetes mellitus. Nutrients. 2019;11(12):2975. https:\/\/doi.org\/10.3390\/nu11122975.","journal-title":"Nutrients"},{"issue":"4","key":"10090_CR4","doi-asserted-by":"publisher","first-page":"104518","DOI":"10.1016\/j.numecd.2025.104518","volume":"36","author":"G Geraci","year":"2026","unstructured":"Geraci G, Ferrara P, Piticchio T, et al. Novel adiposity indices and their role in identifying left ventricular hypertrophy among hypertensive individuals undergoing echocardiography. Nutr Metab Cardiovasc Dis. 2026;36(4):104518. https:\/\/doi.org\/10.1016\/j.numecd.2025.104518.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"10090_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15060229","volume":"15","author":"G Geraci","year":"2025","unstructured":"Geraci G, Ferrara P, Pallotti F, et al. Correlations between novel adiposity indices and electrocardiographic evidence of left ventricular hypertrophy in individuals with arterial hypertension. J Pers Med. 2025;15(6):229. https:\/\/doi.org\/10.3390\/jpm15060229.","journal-title":"J Pers Med"},{"issue":"4","key":"10090_CR6","doi-asserted-by":"publisher","DOI":"10.31083\/IJVNR26559","volume":"95","author":"F Gao","year":"2025","unstructured":"Gao F, Deng C, Luo P. The association between a body shape index and testosterone among U.S. adult males: National Health and Nutrition Examination Survey (2011\u20132016). Int J Vitam Nutr Res. 2025;95(4):26559. https:\/\/doi.org\/10.31083\/IJVNR26559.","journal-title":"Int J Vitam Nutr Res"},{"issue":"1","key":"10090_CR7","doi-asserted-by":"publisher","first-page":"E160","DOI":"10.1152\/ajpendo.00074.2025","volume":"329","author":"ZF Chen","year":"2025","unstructured":"Chen ZF, Shen YF, Gao DW, et al. Metabolic pathways and male fertility: exploring the role of Sertoli cells in energy homeostasis and spermatogenesis. Am J Physiol Endocrinol Metab. 2025;329(1):E160\u201378. https:\/\/doi.org\/10.1152\/ajpendo.00074.2025.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10090_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/157339908783502398","volume":"4","author":"S Amaral","year":"2008","unstructured":"Amaral S, Oliveira PJ, Ramalho-Santos J. Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species. Curr Diabetes Rev. 2008;4(1):46\u201354. https:\/\/doi.org\/10.2174\/157339908783502398.","journal-title":"Curr Diabetes Rev"},{"issue":"2","key":"10090_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2164\/jandrol.111.013193","volume":"33","author":"S La Vignera","year":"2012","unstructured":"La Vignera S, Condorelli R, Vicari E, et al. Diabetes mellitus and sperm parameters. J Androl. 2012;33(2):145\u201353. https:\/\/doi.org\/10.2164\/jandrol.111.013193.","journal-title":"J Androl"},{"issue":"6","key":"10090_CR10","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/andr.12871","volume":"8","author":"R Caltabiano","year":"2020","unstructured":"Caltabiano R, Condorelli D, Panza S, et al. Glucagon-like peptide-1 receptor is expressed in human and rodent testis. Andrology. 2020;8(6):1935\u201345. https:\/\/doi.org\/10.1111\/andr.12871.","journal-title":"Andrology"},{"issue":"2","key":"10090_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","volume":"106","author":"MK Thomas","year":"2021","unstructured":"Thomas MK, Nikooienejad A, Bray R, et al. Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes. J Clin Endocrinol Metab. 2021;106(2):388\u201396. https:\/\/doi.org\/10.1210\/clinem\/dgaa863.","journal-title":"J Clin Endocrinol Metab"},{"key":"10090_CR12","doi-asserted-by":"publisher","first-page":"101398","DOI":"10.1016\/j.mam.2025.101398","volume":"105","author":"F Pallotti","year":"2025","unstructured":"Pallotti F, Buonacquisto A, Cicolani G, et al. Evolution of the incidence of male fertility disorders over the last decades. Mol Aspects Med. 2025;105:101398. https:\/\/doi.org\/10.1016\/j.mam.2025.101398.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"10090_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/cen.70098","volume":"104","author":"NNZ Tun","year":"2026","unstructured":"Tun NNZ, Livingstone DEW, Gibb FW. Low testosterone in men with type 2 diabetes: the role of estrogen excess and aromatase activity. Clin Endocrinol. 2026;104(4):362\u201371. https:\/\/doi.org\/10.1111\/cen.70098.","journal-title":"Clin Endocrinol"},{"key":"10090_CR14","first-page":"297","volume":"135","author":"FJ Hayes","year":"2025","unstructured":"Hayes FJ. Testosterone and insulin resistance in men: evidence for a complex bi-directional relationship. Trans Am Clin Climatol Assoc. 2025;135:297\u2013305.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"10","key":"10090_CR15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/jdi.70127","volume":"16","author":"WH Kang","year":"2025","unstructured":"Kang WH, Sukor N, Kamaruddin NA. Distinct patterns of hypogonadism in a cross-sectional study of Malaysian men with type 2 diabetes mellitus: the role of insulin resistance, visceral adiposity, and aging. J Diabetes Investig. 2025;16(10):1881\u20139. https:\/\/doi.org\/10.1111\/jdi.70127.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"10090_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2026.103423","volume":"20","author":"AA Oroojan","year":"2026","unstructured":"Oroojan AA, Etedali H, Shirani Lapari H. A systematic review on the impact of type 2 diabetes on Leydig and Sertoli cells: molecular mechanisms and functional consequences. Diabetes Metab Syndr. 2026;20(5):103423. https:\/\/doi.org\/10.1016\/j.dsx.2026.103423.","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"10090_CR17","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.3390\/ijms26104579","volume":"26","author":"A Biasi","year":"2025","unstructured":"Biasi A, Ambruosi MR, Romano MZ, et al. Impact of type 1 diabetes on testicular microtubule dynamics, sperm physiology, and male reproductive health in rat. Int J Mol Sci. 2025;26(10):4579. https:\/\/doi.org\/10.3390\/ijms26104579.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10090_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27031268","volume":"27","author":"SH Aladaileh","year":"2026","unstructured":"Aladaileh SH, Abukhalil MH, Alfwuaires MA, et al. Modulation of oxidative stress, inflammation, and apoptosis and restoration of Sirt1\/Nrf2\/HO-1 signaling by diosmin protect against diabetes-induced testicular damage in rats. Int J Mol Sci. 2026;27(3):1268. https:\/\/doi.org\/10.3390\/ijms27031268.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10090_CR19","doi-asserted-by":"publisher","first-page":"e0305636","DOI":"10.1371\/journal.pone.0305636","volume":"19","author":"R Bdeir","year":"2024","unstructured":"Bdeir R, Al-Sawalha NA, Al-Fawares O, et al. Effects of empagliflozin on gonadal functions of hyperglycemic male Wistar rats. PLoS ONE. 2024;19(6):e0305636. https:\/\/doi.org\/10.1371\/journal.pone.0305636.","journal-title":"PLoS ONE"},{"issue":"6","key":"10090_CR20","doi-asserted-by":"publisher","DOI":"10.1071\/RD25089","volume":"38","author":"R Sardar","year":"2026","unstructured":"Sardar R, Abdullah F, Kamsani YS, et al. Synergistic effect of glutathione and metformin mitigates testicular apoptosis by ameliorating gonadotropin hormones and gene expression in streptozotocin-induced diabetic male mice. Reprod Fertil Dev. 2026;38(6):RD25089. https:\/\/doi.org\/10.1071\/RD25089.","journal-title":"Reprod Fertil Dev"},{"key":"10090_CR21","doi-asserted-by":"publisher","first-page":"1021263","DOI":"10.3389\/fendo.2022.1021263","volume":"13","author":"X Xu","year":"2022","unstructured":"Xu X, Luo D, Xuan Q, et al. Atlas of metabolism reveals palmitic acid results in mitochondrial dysfunction and cell apoptosis by inhibiting fatty acid \u03b2-oxidation in Sertoli cells. Front Endocrinol (Lausanne). 2022;13:1021263. https:\/\/doi.org\/10.3389\/fendo.2022.1021263.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10090_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051115","volume":"10","author":"JC Ribeiro","year":"2022","unstructured":"Ribeiro JC, Martins AD, Jarak I, et al. Exenatide and dapagliflozin combination enhances Sertoli cell secretion of key metabolites for spermatogenesis. Biomedicines. 2022;10(5):1115. https:\/\/doi.org\/10.3390\/biomedicines10051115.","journal-title":"Biomedicines"},{"issue":"6","key":"10090_CR23","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/biolre\/ioac052","volume":"106","author":"S Numata","year":"2022","unstructured":"Numata S, McDermott JP, Sanchez G, et al. The sodium-glucose cotransporter isoform 1 (SGLT-1) is important for sperm energetics, motility, and fertility. Biol Reprod. 2022;106(6):1206\u201317. https:\/\/doi.org\/10.1093\/biolre\/ioac052.","journal-title":"Biol Reprod"},{"issue":"2","key":"10090_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","volume":"1","author":"J Chen","year":"2010","unstructured":"Chen J, Williams S, Ho S, et al. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther. 2010;1(2):57\u201392. https:\/\/doi.org\/10.1007\/s13300-010-0006-4.","journal-title":"Diabetes Ther"},{"issue":"6","key":"10090_CR25","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1172\/JCI610","volume":"101","author":"SA Beak","year":"1998","unstructured":"Beak SA, Heath MM, Small CJ, et al. Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J Clin Invest. 1998;101(6):1334\u201341. https:\/\/doi.org\/10.1172\/JCI610.","journal-title":"J Clin Invest"},{"issue":"2","key":"10090_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/biolre\/iox087","volume":"97","author":"A Oride","year":"2017","unstructured":"Oride A, Kanasaki H, Mijiddorj T, et al. GLP-1 increases Kiss-1 mRNA expression in kisspeptin-expressing neuronal cells. Biol Reprod. 2017;97(2):240\u20138. https:\/\/doi.org\/10.1093\/biolre\/iox087.","journal-title":"Biol Reprod"},{"key":"10090_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1224985","volume":"14","author":"MA Fathy","year":"2023","unstructured":"Fathy MA, Alsemeh AE, Habib MA, et al. Liraglutide ameliorates diabetic-induced testicular dysfunction in male rats: role of GLP-1\/Kiss1\/GnRH and TGF-\u03b2\/Smad signaling pathways. Front Pharmacol. 2023;14:1224985. https:\/\/doi.org\/10.3389\/fphar.2023.1224985.","journal-title":"Front Pharmacol"},{"issue":"8","key":"10090_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00592-023-02107-x","volume":"60","author":"E Mannucci","year":"2023","unstructured":"Mannucci E, Candido R, Delle Monache L, et al. 2023 update on Italian guidelines for the treatment of type 2 diabetes. Acta Diabetol. 2023;60(8):1119\u201351. https:\/\/doi.org\/10.1007\/s00592-023-02107-x.","journal-title":"Acta Diabetol"},{"issue":"2","key":"10090_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11020191","volume":"11","author":"K El-Sayed","year":"2022","unstructured":"El-Sayed K, Ali DA, Maher SA, et al. Prophylactic and ameliorative effects of PPAR-\u03b3 agonist pioglitazone in improving oxidative stress, germ cell apoptosis and inflammation in gentamycin-induced testicular damage in adult male albino rats. Antioxidants (Basel). 2022;11(2):191. https:\/\/doi.org\/10.3390\/antiox11020191.","journal-title":"Antioxidants (Basel)"},{"key":"10090_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biocel.2016.08.011","volume":"79","author":"MJ Meneses","year":"2016","unstructured":"Meneses MJ, Bernardino RL, S\u00e1 R, et al. Pioglitazone increases the glycolytic efficiency of human Sertoli cells with possible implications for spermatogenesis. Int J Biochem Cell Biol. 2016;79:52\u201360. https:\/\/doi.org\/10.1016\/j.biocel.2016.08.011.","journal-title":"Int J Biochem Cell Biol"},{"key":"10090_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4137\/cmo.s678","volume":"2","author":"SI Rabbani","year":"2008","unstructured":"Rabbani SI, Devi K, Khanam S. Effect of thiazolidinediones on the erythropoeitic and germinal cells in the male Wistar rats. Clin Med Oncol. 2008;2:423\u20139. https:\/\/doi.org\/10.4137\/cmo.s678.","journal-title":"Clin Med Oncol"},{"issue":"7","key":"10090_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/nu12071932","volume":"12","author":"CY Liu","year":"2020","unstructured":"Liu CY, Chang TC, Lin SH, et al. Metformin ameliorates testicular function and spermatogenesis in male mice with high-fat and high-cholesterol diet-induced obesity. Nutrients. 2020;12(7):1932. https:\/\/doi.org\/10.3390\/nu12071932.","journal-title":"Nutrients"},{"key":"10090_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176388","volume":"968","author":"J Dong","year":"2024","unstructured":"Dong J, Tong X, Xu J, et al. Metformin improves obesity-related oligoasthenospermia via regulating the expression of HSL in testis in mice. Eur J Pharmacol. 2024;968:176388. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176388.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10090_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/iep.12446","volume":"103","author":"JS de Oliveira","year":"2022","unstructured":"de Oliveira JS, Silva AADN, Dias FCR, et al. Histomorphometric and oxidative evaluation of the offspring\u2019s testis from type 2 diabetic female rats treated with metformin and pentoxifylline. Int J Exp Pathol. 2022;103(5):174\u201389. https:\/\/doi.org\/10.1111\/iep.12446.","journal-title":"Int J Exp Pathol"},{"issue":"4","key":"10090_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1071\/RD18256","volume":"31","author":"V Calle-Guisado","year":"2019","unstructured":"Calle-Guisado V, Gonzalez-Fernandez L, Martin-Hidalgo D, et al. Metformin inhibits human spermatozoa motility and signaling pathways mediated by protein kinase A and tyrosine phosphorylation without affecting mitochondrial function. Reprod Fertil Dev. 2019;31(4):787\u201395. https:\/\/doi.org\/10.1071\/RD18256.","journal-title":"Reprod Fertil Dev"},{"issue":"5","key":"10090_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biology13050330","volume":"13","author":"GM Rindone","year":"2024","unstructured":"Rindone GM, Dasso ME, Centola CL, et al. Effect of metformin on Sertoli cell fatty acid metabolism and blood-testis barrier formation. Biol. 2024;13(5):330. https:\/\/doi.org\/10.3390\/biology13050330.","journal-title":"Biol"},{"issue":"1","key":"10090_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5534\/wjmh.210001","volume":"40","author":"CH Tseng","year":"2022","unstructured":"Tseng CH. The effect of metformin on male reproductive function and prostate: an updated review. World J Mens Health. 2022;40(1):11\u201329. https:\/\/doi.org\/10.5534\/wjmh.210001.","journal-title":"World J Mens Health"},{"key":"10090_CR38","doi-asserted-by":"publisher","first-page":"1059942","DOI":"10.3389\/fendo.2022.1059942","volume":"13","author":"P Dana","year":"2022","unstructured":"Dana P, Hayati Roodbari N, Yaghmaei P, et al. Effects of empagliflozin on the expression of kisspeptin gene and reproductive system function in streptozotocin-induced diabetic male rats. Front Endocrinol (Lausanne). 2022;13:1059942. https:\/\/doi.org\/10.3389\/fendo.2022.1059942.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10090_CR39","doi-asserted-by":"publisher","first-page":"116135","DOI":"10.1016\/j.bcp.2024.116135","volume":"223","author":"M Kiani","year":"2024","unstructured":"Kiani M, Soleimani Mehranjani M, Shariatzadeh MA. Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic rats: a stereological and biochemical study. Biochem Pharmacol. 2024;223:116135. https:\/\/doi.org\/10.1016\/j.bcp.2024.116135.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10090_CR40","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.repbio.2024.100971","volume":"25","author":"M Kiani","year":"2025","unstructured":"Kiani M, Mehranjani MS, Shariatzadeh MA. Empagliflozin improves sperm quality in diabetic rats by lowering oxidative stress and reducing apoptosis-related genes expression. Reprod Biol. 2025;25(1):100971. https:\/\/doi.org\/10.1016\/j.repbio.2024.100971.","journal-title":"Reprod Biol"},{"issue":"4","key":"10090_CR41","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.55730\/1300-0144.5443","volume":"52","author":"BU Karaca","year":"2022","unstructured":"Karaca BU, Boran T, K\u00f6ro\u011flu AK, et al. Evaluation of toxic effects of dapagliflozin on reproductive system in diabetic rats. Turk J Med Sci. 2022;52(4):1362\u201370. https:\/\/doi.org\/10.55730\/1300-0144.5443.","journal-title":"Turk J Med Sci"},{"issue":"3","key":"10090_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/aja202242","volume":"25","author":"ZC Luo","year":"2023","unstructured":"Luo ZC, Jin ZR, Jiang YF, et al. The protective effects and underlying mechanisms of dapagliflozin on diabetes-induced testicular dysfunction. Asian J Androl. 2023;25(3):331\u20138. https:\/\/doi.org\/10.4103\/aja202242.","journal-title":"Asian J Androl"},{"issue":"1","key":"10090_CR43","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41598-024-51224-2","volume":"14","author":"Z Jin","year":"2024","unstructured":"Jin Z, Cao Y, Wen Q, et al. Dapagliflozin ameliorates diabetes-induced spermatogenic dysfunction by modulating the adenosine metabolism along the gut microbiota-testis axis. Sci Rep. 2024;14(1):641. https:\/\/doi.org\/10.1038\/s41598-024-51224-2.","journal-title":"Sci Rep"},{"key":"10090_CR44","doi-asserted-by":"publisher","first-page":"107530","DOI":"10.1016\/j.vph.2025.107530","volume":"160","author":"J Hamze","year":"2025","unstructured":"Hamze J, Stone C, Harris DD, et al. Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure. Vascul Pharmacol. 2025;160:107530. https:\/\/doi.org\/10.1016\/j.vph.2025.107530.","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"10090_CR45","doi-asserted-by":"publisher","first-page":"13802","DOI":"10.1038\/s41598-024-64684-3","volume":"14","author":"C Kosinski","year":"2024","unstructured":"Kosinski C, Papadakis GE, Salamin O, et al. Effects of empagliflozin on reproductive system in men without diabetes. Sci Rep. 2024;14(1):13802. https:\/\/doi.org\/10.1038\/s41598-024-64684-3.","journal-title":"Sci Rep"},{"key":"10090_CR46","doi-asserted-by":"publisher","first-page":"108681","DOI":"10.1016\/j.diabres.2021.108681","volume":"173","author":"L D'Onofrio","year":"2021","unstructured":"D\u2019Onofrio L, Mignogna C, Carlone A, et al. Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: a 24 months follow-up study. Diabetes Res Clin Pract. 2021;173:108681. https:\/\/doi.org\/10.1016\/j.diabres.2021.108681.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10090_CR47","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.clinthera.2024.04.009","volume":"46","author":"S Bodini","year":"2024","unstructured":"Bodini S, Pieralice S, D\u2019Onofrio L, et al. No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study. Clin Ther. 2024;46(11):828\u201334. https:\/\/doi.org\/10.1016\/j.clinthera.2024.04.009.","journal-title":"Clin Ther"},{"issue":"8","key":"10090_CR48","doi-asserted-by":"publisher","first-page":"075","DOI":"10.1210\/jendso\/bvaf075","volume":"9","author":"H Wei","year":"2025","unstructured":"Wei H, Ye L, Li M, Huang S, Mo Z. Effect of GLP-1 RA and SGLT2I on biomarkers of oxidative stress in T2DM: a systematic review and meta-analysis. J Endocr Soc. 2025;9(8):075. https:\/\/doi.org\/10.1210\/jendso\/bvaf075.","journal-title":"J Endocr Soc"},{"issue":"1","key":"10090_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12978-023-01684-y","volume":"20","author":"C Cheng","year":"2023","unstructured":"Cheng C, Chen X, Song Y, et al. Genital mycoplasma infection: a systematic review and meta-analysis. Reprod Health. 2023;20(1):136. https:\/\/doi.org\/10.1186\/s12978-023-01684-y.","journal-title":"Reprod Health"},{"issue":"3","key":"10090_CR50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/MOU.0000000000001081","volume":"33","author":"MJ Rivero","year":"2023","unstructured":"Rivero MJ, Kulkarni N, Thirumavalavan N, Ramasamy R. Evaluation and management of male genital tract infections in the setting of male infertility: an updated review. Curr Opin Urol. 2023;33(3):180\u20136. https:\/\/doi.org\/10.1097\/MOU.0000000000001081.","journal-title":"Curr Opin Urol"},{"issue":"5","key":"10090_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/aji.12420","volume":"74","author":"E Zhang","year":"2015","unstructured":"Zhang E, Xu F, Liang H, et al. GLP-1 receptor agonist exenatide attenuates the detrimental effects of obesity on inflammatory profile in testis and sperm quality in mice. Am J Reprod Immunol. 2015;74(5):457\u201366. https:\/\/doi.org\/10.1111\/aji.12420.","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"10090_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4149\/gpb_2022064","volume":"42","author":"EA Abdel-Hakeem","year":"2023","unstructured":"Abdel-Hakeem EA, Zenhom NM, Mokhemer SA. Testicular cytoprotective effect of glucagon like peptide-1 in diabetic rats involves inhibition of apoptosis, endoplasmic reticulum stress and activation of autophagy. Gen Physiol Biophys. 2023;42(2):135\u201348. https:\/\/doi.org\/10.4149\/gpb_2022064.","journal-title":"Gen Physiol Biophys"},{"issue":"5","key":"10090_CR53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1292\/jvms.24-0042","volume":"86","author":"M Iida","year":"2024","unstructured":"Iida M, Asano A. Effects of glucagon-like peptide-1 receptor agonists on spermatogenesis-related gene expression in mouse testis and testis-derived cell lines. J Vet Med Sci. 2024;86(5):555\u201362. https:\/\/doi.org\/10.1292\/jvms.24-0042.","journal-title":"J Vet Med Sci"},{"issue":"1","key":"10090_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01202-0","volume":"22","author":"R Qi","year":"2024","unstructured":"Qi R, Liang Y, Yu J, et al. Liraglutide improved the reproductive function of obese mice by upregulating the testicular AC3\/cAMP\/PKA pathway. Reprod Biol Endocrinol. 2024;22(1):31. https:\/\/doi.org\/10.1186\/s12958-024-01202-0.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"10090_CR55","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12020-025-04245-4","volume":"89","author":"D Yin","year":"2025","unstructured":"Yin D, Li F, Xia L, et al. GLP-1 receptor agonists show no detrimental effect on sperm quality in mouse models and cell lines. Endocrine. 2025;89(2):614\u201326. https:\/\/doi.org\/10.1007\/s12020-025-04245-4.","journal-title":"Endocrine"},{"issue":"4","key":"10090_CR56","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa031","volume":"161","author":"V Rago","year":"2020","unstructured":"Rago V, De Rose D, Santoro M, et al. Human sperm express the receptor for glucagon-like peptide-1 (GLP-1), which affects sperm function and metabolism. Endocrinology. 2020;161(4):bqaa031. https:\/\/doi.org\/10.1210\/endocr\/bqaa031.","journal-title":"Endocrinology"},{"issue":"5","key":"10090_CR57","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.rbmo.2014.07.009","volume":"29","author":"P Fontoura","year":"2014","unstructured":"Fontoura P, Cardoso MC, Erthal-Martins MC, et al. The effects of liraglutide on male fertility: a case report. Reprod Biomed Online. 2014;29(5):644\u20136. https:\/\/doi.org\/10.1016\/j.rbmo.2014.07.009.","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"10090_CR58","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/humrep\/deac096","volume":"37","author":"E Andersen","year":"2022","unstructured":"Andersen E, Juhl CR, Kj\u00f8ller ET, et al. Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial. Hum Reprod. 2022;37(7):1414\u201322. https:\/\/doi.org\/10.1093\/humrep\/deac096.","journal-title":"Hum Reprod"},{"issue":"2","key":"10090_CR59","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/dom.16042","volume":"27","author":"N Gregori\u010d","year":"2025","unstructured":"Gregori\u010d N, \u0160ikonja J, Jane\u017e A, et al. Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism. Diabetes Obes Metab. 2025;27(2):519\u201328. https:\/\/doi.org\/10.1111\/dom.16042.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10090_CR60","doi-asserted-by":"publisher","first-page":"797","DOI":"10.36740\/WLek\/202970","volume":"78","author":"A Alathary","year":"2025","unstructured":"Alathary A, Al-Isawi Z. Tirzepatide therapy counters inflammatory and apoptotic responses induced by high-fat diet in rat liver. Wiad Lek. 2025;78(4):797\u2013805. https:\/\/doi.org\/10.36740\/WLek\/202970.","journal-title":"Wiad Lek"},{"key":"10090_CR61","doi-asserted-by":"publisher","first-page":"1700894","DOI":"10.3389\/fendo.2025.1700894","volume":"16","author":"V Patern\u00f2","year":"2026","unstructured":"Patern\u00f2 V, Geraci G, Piticchio T, et al. Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond weight loss. Front Endocrinol (Lausanne). 2026;16:1700894. https:\/\/doi.org\/10.3389\/fendo.2025.1700894.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10090_CR62","doi-asserted-by":"publisher","first-page":"681939","DOI":"10.3389\/fendo.2021.681939","volume":"12","author":"C Antinozzi","year":"2021","unstructured":"Antinozzi C, Lista M, Caponecchia L, et al. Exploratory analysis in the differences in blood serum and seminal plasma of adipose-tissue related peptides in obese and non-obese men and their correlations with semen parameters. Front Endocrinol (Lausanne). 2021;12:681939. https:\/\/doi.org\/10.3389\/fendo.2021.681939.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10090_CR63","doi-asserted-by":"publisher","first-page":"tfag010","DOI":"10.1093\/toxres\/tfag010","volume":"15","author":"I Albokhadaim","year":"2026","unstructured":"Albokhadaim I. Tirzepatide ameliorates type 2 diabetes-associated male reproductive dysfunction via modulation of the Nrf2\/Keap1 pathway. Toxicol Res (Camb). 2026;15(1):tfag010. https:\/\/doi.org\/10.1093\/toxres\/tfag010.","journal-title":"Toxicol Res (Camb)"},{"issue":"1","key":"10090_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01425-9","volume":"23","author":"S La Vignera","year":"2025","unstructured":"La Vignera S, Cannarella R, Garofalo V, et al. Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study. Reprod Biol Endocrinol. 2025;23(1):92. https:\/\/doi.org\/10.1186\/s12958-025-01425-9.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"10090_CR65","doi-asserted-by":"publisher","first-page":"104","DOI":"10.23736\/S2724-6507.26.04541-0","volume":"51","author":"G Seminara","year":"2026","unstructured":"Seminara G, Leuzzi M, Meduri L, Greco EA, Aversa A. Effects of testosterone undecanoate as add-on therapy in obese hypogonadal men that are late responders to tirzepatide: a pilot study. Minerva Endocrinol. 2026;51(2):104\u201317. https:\/\/doi.org\/10.23736\/S2724-6507.26.04541-0.","journal-title":"Minerva Endocrinol"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10090-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:33:05Z","timestamp":1790825585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-026-10090-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":65,"alternative-id":["10090"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10090-1","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"21 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EM declares the following potential conflicts of interest related to this manuscript: AstraZeneca (speaker in educational events and consultancy), Boehringer-Ingelheim (speaker in educational events), Eli Lilly (speaker in educational events and consultancy), Guidotti (speaker in educational events and travel grants), Merck KGaA (speaker in educational events and consultancy), and Novo Nordisk (speaker in educational events, consultancy, and travel grants). The other authors declare no conflicts of interest related to this manuscript.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}